Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SM
|
Patrick A Lytle
VP - Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 6,776 Reduced 44.68% |
$284,660
$42.01 p/Share
|
Mar 08
2022 |
|
SM
|
Mary Ellen Lutey
SVP - Expl., Development & EHS |
SELL
Open market or private sale
|
Indirect | 9,533 Reduced 21.33% |
$381,034
$39.97 p/Share
|
Mar 08
2022 |
|
UFPI
|
Matthew J Missad
Executive Chairman |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.43% |
$415,000
$83.0 p/Share
|
Mar 08
2022 |
|
MSA
|
Nishan J. Vartanian
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 8,705 Reduced 18.86% |
$1,119,811
$128.64 p/Share
|
Mar 08
2022 |
|
MSA
|
Nishan J. Vartanian
Director |
BUY
Grant, award, or other acquisition
|
Direct | 14,629 Added 24.06% |
-
|
Mar 08
2022 |
|
MSA
|
Steven C. Blanco Sr.
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,145 Reduced 8.96% |
$147,293
$128.64 p/Share
|
Mar 08
2022 |
|
MSA
|
Steven C. Blanco Sr.
CEO |
BUY
Grant, award, or other acquisition
|
Direct | 2,893 Added 18.46% |
-
|
Mar 08
2022 |
|
MSA
|
Jonathan D. Buck
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 182 Reduced 7.62% |
$23,412
$128.64 p/Share
|
Mar 08
2022 |
|
MSA
|
Jonathan D. Buck
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 353 Added 12.87% |
-
|
Mar 08
2022 |
|
MSA
|
Kenneth D. Krause
Senior VP, CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,210 Reduced 11.79% |
$284,294
$128.64 p/Share
|
Mar 08
2022 |
|
MSA
|
Kenneth D. Krause
Senior VP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 3,655 Added 16.31% |
-
|
Mar 08
2022 |
|
MSA
|
Stephanie L Sciullo
President |
SELL
Payment of exercise price or tax liability
|
Direct | 175 Reduced 3.1% |
$22,512
$128.64 p/Share
|
Mar 08
2022 |
|
MSA
|
Stephanie L Sciullo
President |
BUY
Grant, award, or other acquisition
|
Direct | 321 Added 5.38% |
-
|
Mar 08
2022 |
|
MSA
|
Bob Willem Leenen
Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 116 Reduced 0.98% |
$14,922
$128.64 p/Share
|
Mar 08
2022 |
|
MSA
|
Bob Willem Leenen
Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 1,070 Added 8.33% |
-
|
Mar 08
2022 |
|
PSB
|
Maria R Hawthorne
Interim COO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,944 Reduced 3.4% |
$309,738
$159.33 p/Share
|
Mar 08
2022 |
|
PSB
|
Trenton Groves
SVP, CAO & Asst. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct | 191 Reduced 2.14% |
$30,432
$159.33 p/Share
|
Mar 08
2022 |
|
RYN
|
April J. Tice
SVP & CFO |
SELL
Open market or private sale
|
Direct | 1,850 Reduced 13.62% |
$77,256
$41.76 p/Share
|
Mar 08
2022 |
|
RYN
|
April J. Tice
SVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,850 Added 11.99% |
$64,732
$34.99 p/Share
|
Mar 08
2022 |
|
MP
|
Daniel Allen Gold
Director |
SELL
Open market or private sale
|
Indirect | 205,235 Reduced 2.63% |
$9,034,445
$44.02 p/Share
|
Mar 08
2022 |
|
MP
|
Daniel Allen Gold
Director |
SELL
Open market or private sale
|
Indirect | 394,765 Reduced 1.38% |
$17,302,551
$43.83 p/Share
|
Mar 08
2022 |
|
GMED
|
James R Tobin |
SELL
Open market or private sale
|
Direct | 4,484 Reduced 100.0% |
$322,848
$72.0 p/Share
|
Mar 08
2022 |
|
GMED
|
James R Tobin |
BUY
Exercise of conversion of derivative security
|
Direct | 4,484 Added 50.0% |
$195,413
$43.58 p/Share
|
Mar 08
2022 |
|
COTY
|
Gordon Von Bretten
Director |
BUY
Open market or private purchase
|
Direct | 13,514 Added 7.59% |
$100,004
$7.4 p/Share
|
Mar 08
2022 |
|
ESTC
|
Ashutosh Kulkarni
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 71,445 Added 33.3% |
-
|
Mar 08
2022 |
|
ESTC
|
Janesh Moorjani
CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct | 29,768 Added 26.65% |
-
|
Mar 08
2022 |
|
HOOD
|
Jason Warnick
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 4.67% |
$232,800
$11.64 p/Share
|
Mar 08
2022 |
|
AMC
|
Kevin M Connor
SVP, Gen Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 92.51% |
$752,500
$15.05 p/Share
|
Mar 08
2022 |
|
CDAY
|
Christopher R Armstrong
EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 8,604 Added 6.81% |
-
|
Mar 08
2022 |
|
CDAY
|
Noemie Clemence Heuland
EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,224 Added 3.51% |
-
|
Mar 08
2022 |
|
CDAY
|
Stephen H. Holdridge
President, COO |
BUY
Exercise of conversion of derivative security
|
Direct | 5,127 Added 10.2% |
-
|
Mar 08
2022 |
|
CDAY
|
Jeffrey Scott Jacobs
Head of Acct & Fin Reporting |
BUY
Exercise of conversion of derivative security
|
Direct | 1,416 Added 12.37% |
-
|
Mar 08
2022 |
|
CDAY
|
Joseph B Korngiebel
EVP, CSPTO |
BUY
Exercise of conversion of derivative security
|
Direct | 8,585 Added 7.05% |
-
|
Mar 08
2022 |
|
CDAY
|
William Everett Mc Donald
EVP, CLO, & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 2,199 Added 5.36% |
-
|
Mar 08
2022 |
|
DXCM
|
Donald Abbey
EVP Global Business Services I |
BUY
Grant, award, or other acquisition
|
Direct | 4,984 Added 8.5% |
-
|
Mar 08
2022 |
|
DXCM
|
Andrew K Balo
EVP Regulatory Strategy Clinic |
BUY
Grant, award, or other acquisition
|
Direct | 4,984 Added 20.74% |
-
|
Mar 08
2022 |
|
DXCM
|
Michael Jon Brown
EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 12,038 Added 50.0% |
-
|
Mar 08
2022 |
|
DXCM
|
Matthew Vincent Dolan
EVP, Strategy & Corporate Dev |
BUY
Grant, award, or other acquisition
|
Direct | 2,889 Added 21.68% |
-
|
Mar 08
2022 |
|
DXCM
|
Paul R Flynn
EVP Global Revenue |
BUY
Grant, award, or other acquisition
|
Direct | 5,297 Added 21.67% |
-
|
Mar 08
2022 |
|
DXCM
|
Jacob Steven Leach
EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,741 Added 7.86% |
-
|
Mar 08
2022 |
|
DXCM
|
Steven Robert Pacelli
EVP Managing Director Dexcom V |
BUY
Grant, award, or other acquisition
|
Direct | 4,984 Added 11.24% |
-
|
Mar 08
2022 |
|
DXCM
|
Chad Patterson
EVP Global Marketing |
BUY
Grant, award, or other acquisition
|
Direct | 5,297 Added 22.91% |
-
|
Mar 08
2022 |
|
DXCM
|
Barry J. Regan
EVP Operations |
BUY
Grant, award, or other acquisition
|
Direct | 4,984 Added 21.58% |
-
|
Mar 08
2022 |
|
DXCM
|
Kevin R Sayer
Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct | 16,251 Added 12.78% |
-
|
Mar 08
2022 |
|
DXCM
|
Shelly Ramasamy Selvaraj
SVP Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,889 Added 15.55% |
-
|
Mar 08
2022 |
|
DXCM
|
Sumi Shrishrimal
SVP Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,889 Added 16.02% |
-
|
Mar 08
2022 |
|
DXCM
|
Sadie Stern
EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,297 Added 22.02% |
-
|
Mar 08
2022 |
|
DXCM
|
Jereme M Sylvain
EVP, Chief Financal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,297 Added 20.97% |
-
|
Mar 08
2022 |
|
OGE
|
Cristina F Mc Quistion
VP- Corp. Resp.& Stewardship |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 7.93% |
$86,702
$39.41 p/Share
|
Mar 08
2022 |
|
COLD
|
James Andrew Harron
EVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,438 Reduced 7.13% |
$38,855
$27.02 p/Share
|
Mar 08
2022 |